Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?

Bibliographic Details
Main Authors: Johannes Boltze, Koji Abe, Andrew N. Clarkson, Oliver Detante, Pedro M. Pimentel-Coelho, Paulo H. Rosado-de-Castro, Miroslaw Janowski
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00171/full
_version_ 1828229522168741888
author Johannes Boltze
Koji Abe
Andrew N. Clarkson
Oliver Detante
Oliver Detante
Pedro M. Pimentel-Coelho
Pedro M. Pimentel-Coelho
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Miroslaw Janowski
Miroslaw Janowski
author_facet Johannes Boltze
Koji Abe
Andrew N. Clarkson
Oliver Detante
Oliver Detante
Pedro M. Pimentel-Coelho
Pedro M. Pimentel-Coelho
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Miroslaw Janowski
Miroslaw Janowski
author_sort Johannes Boltze
collection DOAJ
first_indexed 2024-04-12T18:35:04Z
format Article
id doaj.art-aaaae56a613249a3ab0f70a3ddaacf2d
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-12T18:35:04Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-aaaae56a613249a3ab0f70a3ddaacf2d2022-12-22T03:20:58ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-04-011110.3389/fneur.2020.00171518487Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?Johannes Boltze0Koji Abe1Andrew N. Clarkson2Oliver Detante3Oliver Detante4Pedro M. Pimentel-Coelho5Pedro M. Pimentel-Coelho6Paulo H. Rosado-de-Castro7Paulo H. Rosado-de-Castro8Paulo H. Rosado-de-Castro9Miroslaw Janowski10Miroslaw Janowski11School of Life Sciences, University of Warwick, Coventry, United KingdomDepartment of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, JapanDepartment of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New ZealandStroke Unit, Neurology Department, Grenoble Hospital, Grenoble, FranceGrenoble Institute of Neurosciences, Inserm U1216, Université Grenoble Alpes, Grenoble, FranceInstituto de Biofísica Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilInstituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, BrazilInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilDepartment of Radiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil0D'Or Institute for Research and Education, Rio de Janeiro, Brazil1Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, United States2NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Polandhttps://www.frontiersin.org/article/10.3389/fneur.2020.00171/fullstem cellsstrokemesenchymal stem cells (MSC)braintreatmenttranslational medicine
spellingShingle Johannes Boltze
Koji Abe
Andrew N. Clarkson
Oliver Detante
Oliver Detante
Pedro M. Pimentel-Coelho
Pedro M. Pimentel-Coelho
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Paulo H. Rosado-de-Castro
Miroslaw Janowski
Miroslaw Janowski
Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
Frontiers in Neurology
stem cells
stroke
mesenchymal stem cells (MSC)
brain
treatment
translational medicine
title Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
title_full Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
title_fullStr Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
title_full_unstemmed Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
title_short Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
title_sort editorial cell based therapies for stroke promising solution or dead end
topic stem cells
stroke
mesenchymal stem cells (MSC)
brain
treatment
translational medicine
url https://www.frontiersin.org/article/10.3389/fneur.2020.00171/full
work_keys_str_mv AT johannesboltze editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT kojiabe editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT andrewnclarkson editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT oliverdetante editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT oliverdetante editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT pedrompimentelcoelho editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT pedrompimentelcoelho editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT paulohrosadodecastro editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT paulohrosadodecastro editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT paulohrosadodecastro editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT miroslawjanowski editorialcellbasedtherapiesforstrokepromisingsolutionordeadend
AT miroslawjanowski editorialcellbasedtherapiesforstrokepromisingsolutionordeadend